Zhejiang Int'L Group Co Ltd - Asset Resilience Ratio
Zhejiang Int'L Group Co Ltd (000411) has an Asset Resilience Ratio of 0.00% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Zhejiang Int'L Group Co Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1993–2022)
This chart shows how Zhejiang Int'L Group Co Ltd's Asset Resilience Ratio has changed over time. See what is Zhejiang Int'L Group Co Ltd's book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Int'L Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang Int'L Group Co Ltd market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.00 | 0.0% |
| Total Liquid Assets | CN¥1.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Int'L Group Co Ltd maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Int'L Group Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Int'L Group Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AbbVie Inc
NYSE:ABBV |
Drug Manufacturers - General | 0.02% |
|
Roche Holding AG
SW:ROG |
Drug Manufacturers - General | 15.37% |
|
Biogen Inc
NASDAQ:BIIB |
Drug Manufacturers - General | 2.74% |
|
CSPC Pharmaceutical Group Limited
F:CVG |
Drug Manufacturers - General | 4.64% |
|
AstraZeneca PLC
LSE:AZN |
Drug Manufacturers - General | 0.03% |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
Drug Manufacturers - General | 0.53% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
|
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
Drug Manufacturers - General | 10.10% |
Annual Asset Resilience Ratio for Zhejiang Int'L Group Co Ltd (1993–2022)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Int'L Group Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | -1.28% | CN¥-168.87 Million ≈ $-24.71 Million |
CN¥13.16 Billion ≈ $1.93 Billion |
+0.60pp |
| 2021-12-31 | -1.88% | CN¥-230.20 Million ≈ $-33.69 Million |
CN¥12.25 Billion ≈ $1.79 Billion |
+0.32pp |
| 2020-12-31 | -2.20% | CN¥-247.16 Million ≈ $-36.17 Million |
CN¥11.25 Billion ≈ $1.65 Billion |
+0.19pp |
| 2019-12-31 | -2.39% | CN¥-257.34 Million ≈ $-37.66 Million |
CN¥10.77 Billion ≈ $1.58 Billion |
-1.52pp |
| 2018-12-31 | -0.87% | CN¥-78.28 Million ≈ $-11.46 Million |
CN¥8.99 Billion ≈ $1.32 Billion |
-0.13pp |
| 2017-12-31 | -0.74% | CN¥-67.63 Million ≈ $-9.90 Million |
CN¥9.08 Billion ≈ $1.33 Billion |
+0.31pp |
| 2016-12-31 | -1.06% | CN¥-73.89 Million ≈ $-10.81 Million |
CN¥6.99 Billion ≈ $1.02 Billion |
+0.02pp |
| 2015-12-31 | -1.07% | CN¥-65.77 Million ≈ $-9.62 Million |
CN¥6.12 Billion ≈ $896.28 Million |
-1.08pp |
| 2013-12-31 | 0.01% | CN¥248.89K ≈ $36.42K |
CN¥4.80 Billion ≈ $702.04 Million |
0.00pp |
| 2012-12-31 | 0.01% | CN¥269.31K ≈ $39.41K |
CN¥4.11 Billion ≈ $601.45 Million |
+0.00pp |
| 2011-12-31 | 0.01% | CN¥237.12K ≈ $34.70K |
CN¥3.68 Billion ≈ $538.36 Million |
+0.01pp |
| 2001-12-31 | 0.00% | CN¥2.00K ≈ $292.66 |
CN¥599.40 Million ≈ $87.71 Million |
-0.02pp |
| 2000-12-31 | 0.02% | CN¥57.00K ≈ $8.34K |
CN¥292.30 Million ≈ $42.77 Million |
+0.02pp |
| 1996-12-31 | 0.00% | CN¥12.51K ≈ $1.83K |
CN¥488.64 Million ≈ $71.50 Million |
-0.04pp |
| 1995-12-31 | 0.04% | CN¥147.38K ≈ $21.57K |
CN¥383.42 Million ≈ $56.11 Million |
-0.16pp |
| 1994-12-31 | 0.20% | CN¥576.90K ≈ $84.42K |
CN¥288.35 Million ≈ $42.20 Million |
-1.92pp |
| 1993-12-31 | 2.12% | CN¥5.10 Million ≈ $746.29K |
CN¥240.07 Million ≈ $35.13 Million |
-- |
About Zhejiang Int'L Group Co Ltd
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. It offers chemical drugs, biological products, and Chinese patent medicine. The company was founded in 1950 and is based in Hangzhou, China.